Top 10 Companies in the Southeast Asia CROCIN Market (2026): Market Leaders Powering Regional Innovation

MARKET INSIGHTS

The Southeast Asia CROCIN market was valued at USD 210 million in 2023 and is projected to reach USD 320 million by 2030, growing at a CAGR of 6.2% during the forecast period. Indonesia and Vietnam currently dominate the regional market, accounting for over 45% of total consumption, while Thailand shows the fastest growth potential with an anticipated 7.8% CAGR.

CROCIN (crocetin di‑glucose ester) is a natural carotenoid compound primarily derived from saffron and gardenia flowers. As a water‑soluble pigment, it finds extensive application as a food colorant (E164) and nutritional supplement. The compound’s pharmacological properties, including antioxidant and neuroprotective effects, have driven its adoption in nutraceuticals and traditional medicine formulations across the region.

Market growth is propelled by increasing demand for natural food additives, particularly in Indonesia’s thriving snack food sector, and Vietnam’s expanding functional beverage industry. However, supply chain constraints for raw materials and stringent food safety regulations present ongoing challenges. Recent developments include Malaysia’s National Pharmaceutical Regulatory Agency approving crocin‑based supplements for ophthalmic health in Q1 2024, signaling new therapeutic applications.

Southeast Asia CROCIN Market – View in Detailed Research Report

Top 10 Companies in the Southeast Asia CROCIN Market (2026)

---

1️⃣ Bayer AG

Headquarters: Leverkusen, Germany
Key Offering: High‑purity CROCIN for pharmaceutical and food applications

Bayer’s CROCIN portfolio is supported by a global research network that focuses on natural product extraction and quality control. The company supplies premium grades to leading pharmaceutical manufacturers and food technologists across Southeast Asia.

Sustainability & Growth Initiatives:

• Investment in renewable saffron cultivation projects in Indonesia
• Partnerships with local universities for green extraction technology
• Commitment to reduce CO₂ emissions in production by 15% by 2030

---

2️⃣ GlaxoSmithKline Plc

Headquarters: London, United Kingdom
Key Offering: CROCIN‑based nutraceuticals and ophthalmic supplements

GSK leverages its global pharmaceutical expertise to develop CROCIN formulations that meet stringent safety and efficacy standards, particularly for pain management and eye health.

Sustainability & Growth Initiatives:

• Launch of a regional R&D hub in Singapore focused on plant‑based therapeutics
• Collaboration with Malaysian regulators for accelerated approval pathways
• Goal of 20% increase in market share in Indonesia and Vietnam by 2028

---

3️⃣ PT Kalbe Farma Tbk

Headquarters: Jakarta, Indonesia
Key Offering: Bulk CROCIN for local pharmaceutical and nutraceutical manufacturing

Kalbe Farma’s local sourcing strategy reduces import dependence and supports the Indonesian government’s push for self‑sufficiency in essential medicines.

Sustainability & Growth Initiatives:

• Expansion of in‑house saffron processing facility by 30% capacity
• Implementation of ISO 14001 environmental management system
• Partnership with Indonesian Ministry of Health for national pain‑management programs

---

4️⃣ Sanofi S.A.

Headquarters: Paris, France
Key Offering: CROCIN‑enriched analgesic tablets and dietary supplements

Sanofi’s extensive global distribution network enables rapid deployment of CROCIN products across Southeast Asia, with a focus on pain relief and anti‑inflammatory applications.

Sustainability & Growth Initiatives:

• Investment in AI‑driven quality control for extraction processes
• Collaboration with ASEAN regulatory bodies to harmonize safety standards
• Targeting 25% growth in the nutraceutical segment by 2030

---

5️⃣ Novartis International AG

Headquarters: Basel, Switzerland
Key Offering: High‑purity CROCIN for ophthalmic and dermatological formulations

Novartis’ focus on ophthalmology aligns with recent regulatory approvals in Malaysia, positioning it as a key player in eye‑care markets.

Sustainability & Growth Initiatives:

• Research partnership with local universities on saffron bio‑engineering
• Commitment to zero‑waste production lines by 2035
• Expansion of distribution into Vietnam and Thailand by 2027

---

6️⃣ SmartChem Technology

Headquarters: Singapore
Key Offering: Customized CROCIN blends for food and cosmetic industries

SmartChem’s technology platform allows for precise control over purity and functional properties, catering to niche markets such as halal food and natural cosmetics.

Sustainability & Growth Initiatives:

• Development of a proprietary supercritical CO₂ extraction system
• Partnership with Malaysian halal certification agencies
• Goal of 15% market share in the cosmetic segment by 2030

---

7️⃣ Pfizer Inc.

Headquarters: New York, United States
Key Offering: CROCIN‑based active pharmaceutical ingredients (APIs) for analgesics

Pfizer’s extensive API manufacturing capabilities enable efficient supply to regional pharmaceutical companies.

Sustainability & Growth Initiatives:

• Investment in green chemistry initiatives across Southeast Asia
• Collaboration with ASEAN governments on generic drug policies
• Targeting 10% increase in API production capacity by 2029

---

8️⃣ Hovid Berhad

Headquarters: Kuala Lumpur, Malaysia
Key Offering: CROCIN formulations for traditional medicine and herbal supplements

Hovid’s deep understanding of local herbal medicine markets positions it as a preferred supplier for traditional formulations.

Sustainability & Growth Initiatives:

• Implementation of sustainable saffron sourcing contracts
• Partnership with Malaysian Health Ministry for quality assurance
• Expansion of product line into anti‑inflammatory creams by 2028

---

9️⃣ DKSH Holding Ltd.

Headquarters: Zürich, Switzerland
Key Offering: Distribution network for CROCIN products across Southeast Asia

DKSH’s logistics expertise facilitates rapid market penetration for CROCIN suppliers, especially in rural and archipelagic regions.

Sustainability & Growth Initiatives:

• Digital supply‑chain platform to reduce lead times
• Partnership with local distributors for cold‑chain logistics
• Goal of 20% reduction in transportation emissions by 2032

---

🔟 Mitsubishi Chemical Corporation

Headquarters: Tokyo, Japan
Key Offering: Chemical intermediates derived from CROCIN for specialty applications

Mitsubishi’s chemical expertise supports the development of advanced CROCIN derivatives used in high‑value industrial processes.

Sustainability & Growth Initiatives:

• Investment in sustainable extraction technologies
• Collaboration with ASEAN chemical industry associations
• Targeting 15% growth in specialty chemical markets by 2035

---

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/275165/asia-southeast-crocin-forecast-market

Get Full Report: https://www.24chemicalresearch.com/reports/275165/asia-southeast-crocin-forecast-market

Outlook: The Future of Southeast Asia CROCIN Market

The Southeast Asia CROCIN market is poised for sustained growth, driven by increasing consumer demand for natural food additives and the expanding therapeutic use of CROCIN in pain management and ophthalmology. The region’s strong regulatory harmonization efforts and digital transformation of pharmaceutical supply chains are expected to lower entry barriers and accelerate market penetration.

Key Trends Shaping the Market:

• Rapid adoption of high‑purity CROCIN in premium food products and functional beverages
• Expansion of CROCIN‑based nutraceuticals targeting anti‑oxidant and neuroprotective benefits
• Growth of e‑pharmacy platforms as a major distribution channel for OTC analgesics
• Increasing focus on sustainable extraction technologies and renewable sourcing of saffron
• Regulatory convergence across ASEAN enabling streamlined product approvals

For deeper insights into market dynamics, competitive landscape, and regional opportunities, download the full research report.